Perioperative use of disease modifying anti‐rheumatic drugs (DMARDs) in people with inflammatory arthritis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of perioperative interruption versus continuation of biologic, conventional synthetic, and targeted synthetic disease modifying anti‐rheumatic drugs in people with inflammatory ar...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane database of systematic reviews 2022-05, Vol.2022 (5)
Main Authors: Ponkilainen, Ville, Karjalainen, Teemu V, Kuitunen, Ilari, Uimonen, Mikko, Johnston, Renea V, Saarinen, Antti, Whittle, Samuel L, Avery, Jodie C, Glennon, Vanessa, Grobler, Liesl, Buchbinder, Rachelle
Format: Article
Language:English
Subjects:
Medicine General & Introductory Medical Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of perioperative interruption versus continuation of biologic, conventional synthetic, and targeted synthetic disease modifying anti‐rheumatic drugs in people with inflammatory arthritis, in terms of worsening of underlying inflammatory disease and postoperative complications, such as infection and altered wound healing.
ISSN:1469-493X
DOI:10.1002/14651858.CD015096